Sarepta Therapeutics (SRPT) Other Gross PP&E Adjustments (2011 - 2026)
Sarepta Therapeutics' quarterly Other Gross PP&E Adjustments came in at -$144.9 million in Q1 2026, up 15.04% year-on-year from -$126.0 million in Q1 2025, and down 130.02% quarter-over-quarter from $482.7 million in Q4 2025.
Sarepta Therapeutics has reported Other Gross PP&E Adjustments for 16 years, with the latest figure at -$144.9 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 15.04% year-over-year to -$144.9 million; the trailing twelve-month figure through Mar 2026 stood at -$144.9 million (up 15.04% YoY), and the FY2025 full-year result was $482.7 million, up 18.17% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$144.9 million, down from $482.7 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $482.7 million in Q4 2025, with the low at -$170.6 million in Q1 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$12.3 million, with a median of -$124.0 million recorded in 2024.
- Year-over-year, Other Gross PP&E Adjustments tumbled 176.7% in 2023 and surged 50.74% in 2024.
- Tracing SRPT's Other Gross PP&E Adjustments over 5 years: stood at $251.9 million in 2022, then increased by 7.58% to $271.0 million in 2023, then soared by 50.74% to $408.5 million in 2024, then increased by 18.17% to $482.7 million in 2025, then plunged by 130.02% to -$144.9 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$144.9 million (Q1 2026), $482.7 million (Q4 2025), and -$158.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -144.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -144.90 Mn |
| Mar 31, 2026 | -144.90 Mn |
| Dec 31, 2025 | 482.71 Mn |
| Dec 31, 2025 | 482.71 Mn |
| Sep 30, 2025 | -157.99 Mn |
| Sep 30, 2025 | -157.99 Mn |
| Jun 30, 2025 | -169.65 Mn |
| Jun 30, 2025 | -169.65 Mn |
| Mar 31, 2025 | -170.55 Mn |
| Mar 31, 2025 | -170.55 Mn |
| Dec 31, 2024 | 408.48 Mn |
| Dec 31, 2024 | 408.48 Mn |
| Sep 30, 2024 | -140.90 Mn |
| Sep 30, 2024 | -140.90 Mn |
| Jun 30, 2024 | -124.00 Mn |
| Jun 30, 2024 | -124.00 Mn |
| Mar 31, 2024 | -147.28 Mn |
| Mar 31, 2024 | -147.28 Mn |
| Dec 31, 2023 | 270.99 Mn |
| Dec 31, 2023 | 270.99 Mn |
| Sep 30, 2023 | -157.50 Mn |
| Sep 30, 2023 | -157.50 Mn |
| Jun 30, 2023 | -154.71 Mn |
| Jun 30, 2023 | -154.71 Mn |
| Mar 31, 2023 | -80.99 Mn |
| Mar 31, 2023 | -80.99 Mn |
| Dec 31, 2022 | 251.90 Mn |
| Dec 31, 2022 | 251.90 Mn |
| Sep 30, 2022 | -56.92 Mn |
| Sep 30, 2022 | -56.92 Mn |
| Jun 30, 2022 | -60.57 Mn |
| Jun 30, 2022 | -60.57 Mn |
| Mar 31, 2022 | -56.63 Mn |
| Mar 31, 2022 | -56.63 Mn |
| Dec 31, 2021 | 248.88 Mn |
| Dec 31, 2021 | 248.88 Mn |
| Sep 30, 2021 | -81.59 Mn |
| Sep 30, 2021 | -81.59 Mn |
| Jun 30, 2021 | -81.52 Mn |
| Jun 30, 2021 | -81.52 Mn |
| Mar 31, 2021 | -76.06 Mn |
| Mar 31, 2021 | -76.06 Mn |
| Dec 31, 2020 | 164.48 Mn |
| Dec 31, 2020 | 164.48 Mn |
| Sep 30, 2020 | -81.59 Mn |
| Sep 30, 2020 | -81.59 Mn |
| Jun 30, 2020 | -83.78 Mn |
| Jun 30, 2020 | -83.78 Mn |
| Mar 31, 2020 | -74.32 Mn |
| Mar 31, 2020 | -74.32 Mn |
| Dec 31, 2019 | 131.98 Mn |
| Dec 31, 2019 | 131.98 Mn |
| Sep 30, 2019 | -51.44 Mn |
| Sep 30, 2019 | -51.44 Mn |
| Jun 30, 2019 | -48.41 Mn |
| Jun 30, 2019 | -48.41 Mn |
| Mar 31, 2019 | -49.10 Mn |
| Mar 31, 2019 | -49.10 Mn |
| Dec 31, 2018 | 113.85 Mn |
| Dec 31, 2018 | 113.85 Mn |
| Sep 30, 2018 | -9.11 Mn |
| Sep 30, 2018 | -9.11 Mn |
| Jun 30, 2018 | -7.58 Mn |
| Jun 30, 2018 | -7.58 Mn |
| Mar 31, 2018 | -10.35 Mn |
| Mar 31, 2018 | -10.35 Mn |
| Dec 31, 2017 | 54.38 Mn |
| Dec 31, 2017 | 54.38 Mn |
| Sep 30, 2017 | -5.52 Mn |
| Sep 30, 2017 | -5.52 Mn |
| Jun 30, 2017 | -5.01 Mn |
| Jun 30, 2017 | -5.01 Mn |
| Mar 31, 2017 | -3.76 Mn |
| Mar 31, 2017 | -3.76 Mn |
| Dec 31, 2016 | 65.35 Mn |
| Dec 31, 2016 | 65.35 Mn |
| Sep 30, 2016 | -2.28 Mn |
| Sep 30, 2016 | -2.28 Mn |
| Jun 30, 2016 | -2.60 Mn |
| Jun 30, 2016 | -2.60 Mn |
| Mar 31, 2016 | -2.96 Mn |
| Mar 31, 2016 | -2.96 Mn |
| Dec 31, 2015 | 57.68 Mn |
| Dec 31, 2015 | 57.68 Mn |
| Sep 30, 2015 | -3.35 Mn |
| Sep 30, 2015 | -3.35 Mn |
| Jun 30, 2015 | -1.92 Mn |
| Jun 30, 2015 | -1.92 Mn |
| Mar 31, 2015 | -2.54 Mn |
| Mar 31, 2015 | -2.54 Mn |
| Dec 31, 2014 | 54.99 Mn |
| Dec 31, 2014 | 54.99 Mn |
| Sep 30, 2014 | -2.68 Mn |
| Sep 30, 2014 | -2.68 Mn |
| Jun 30, 2014 | -3.44 Mn |
| Jun 30, 2014 | -3.44 Mn |
| Mar 31, 2014 | 35.63 Mn |
| Mar 31, 2014 | 35.63 Mn |
| Dec 31, 2013 | 13.64 Mn |
| Dec 31, 2013 | 13.64 Mn |
| Dec 31, 2012 | 20.11 Mn |
| Dec 31, 2012 | 20.11 Mn |
| Sep 30, 2012 | -7.28 |
| Sep 30, 2012 | -7.28 |
| Jun 30, 2012 | -5.52 |
| Jun 30, 2012 | -5.52 |
| Dec 31, 2011 | 20.03 Mn |
| Dec 31, 2011 | 20.03 Mn |